Bio-Path Holdings, Inc. (BPTH)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 2.7600 |
| Open | 2.7600 |
| Bid | 2.7300 x 100 |
| Ask | 2.8600 x 100 |
| Day's range | 2.6500 - 2.8600 |
| 52-week range | 2.3500 - 44.8000 |
| Volume | |
| Avg. volume | 1,490,227 |
| Market cap | 4.399M |
| Beta (5Y monthly) | 0.45 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Bio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study
Bio-Path (BPTH) gains 30% on encouraging developmental updates from the early-stage study of its investigational candidate, BP1002, to treat acute myeloid leukemia patients.
- Insider Monkey
Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q4 2023 Earnings Call Transcript
Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q4 2023 Earnings Call Transcript March 8, 2024 Bio-Path Holdings, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and gentlemen, and welcome to the Bio-Path Holdings Full Year 2023 Earnings Conference Call. […]
- Thomson Reuters StreetEvents
Q4 2023 Bio Path Holdings Inc Earnings Call
Q4 2023 Bio Path Holdings Inc Earnings Call
© 2024 Yahoo. All rights reserved.